EMA's pilot on "staggered approval" of new drugs may be delayed
This article was originally published in SRA
Executive Summary
Plans by the European Medicines Agency to launch a pilot project on introducing staggered approvals of new drugs might be delayed, a spokesperson for the agency has told Scrip Regulatory Affairs1,2.